Tag Archives | V Vaccine

The “V” Vaccine Aids in Recovery for Melanoma Patients

Dr. James Mulé is the Executive Vice President for Translational Research and the Michael McGillicuddy Endowed Chair for Melanoma at the Moffitt Cancer Center in Tampa, FL.  Dr. Mulé received a $1 million designated grant from The V Foundation in 2007 to support research about melanoma.  The grant has allowed Dr. Mulé to explore immune-based therapies and tumor vaccines. Skin cancer is the most common type of all cancers, and the number of skin cancer cases continues to rise in the U.S. to over one million diagnoses each year.  Dr. Mulé leads a team of skin cancer researchers at Moffit […]

Read full story Comments { 0 }

The V Foundation Reaches Another New Milestone!

The V Foundation has now awarded $80 million to grants for cancer research!  We have awarded over 400 grants to scientists and researchers nationwide. These grants are making a huge difference in the field of cancer research.  Among the many achievements and strides made by our researchers is the V Vaccine, developed by Dr. James Mulé at the Moffitt Cancer Center.  This vaccine is a new vaccine for melanoma patients that creates new functioning lymph nodes in the body.  This vaccine, the first of its kind, is expected to set the stage for vaccines that will boost immunity to a […]

Read full story Comments { 0 }